Real-time enrollment status for this common warts (verruca vulgaris) clinical trial
Current Status
Recruiting
Checked: September 3, 2026 at 6:35 AM UTC
| NCT Number | NCT07457918 |
| Recruiting Status | Recruiting |
| Condition | Common Warts (Verruca Vulgaris) |
| Phase | PHASE3 |
| Target Enrollment | 600 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Verrica Pharmaceuticals Inc. |
| Last Updated on CT.gov | May 5, 2026 (May 5, 2026) |
As of September 3, 2026: Clinical trial NCT07457918 is currently recruiting participants. This phase3 study for common warts (verruca vulgaris) is actively seeking new participants at 4 locations across the United States. The study is sponsored by Verrica Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07457918 is actively recruiting participants as of September 3, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07457918 was last updated May 5, 2026 (May 5, 2026). HelloStudys verifies this status automatically.